Found: 8
Select item for more details and to access through your institution.
Hematology Quiz - Case 32 A.
- Published in:
- Archives of Hellenic Medicine / Arheia Ellenikes Iatrikes, 2012, v. 29, n. 6, p. 761
- By:
- Publication type:
- Article
Hematology Quiz - Case 28.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites.
- Published in:
- European Journal of Haematology, 2001, v. 67, n. 5/6, p. 279, doi. 10.1034/j.1600-0609.2001.00561.x
- By:
- Publication type:
- Article
PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB‐CHOP (RCHOP) ± RADIOTHERAPY (RT).
- Published in:
- Hematological Oncology, 2019, v. 37, p. 266, doi. 10.1002/hon.76_2630
- By:
- Publication type:
- Article
CLONAL B‐CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL‐MZ): DESCRIPTION OF MAIN CLINICAL FEATURES, DISEASE EVOLUTION AND OUTCOME IN A SERIES OF 100 PATIENTS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 223, doi. 10.1002/hon.38_2630
- By:
- Publication type:
- Article
PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB‐CHOP (RCHOP) ± RADIOTHERAPY (RT).
- Published in:
- Hematological Oncology, 2019, v. 37, p. 266, doi. 10.1002/hon.76_2630
- By:
- Publication type:
- Article
CLONAL B‐CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL‐MZ): DESCRIPTION OF MAIN CLINICAL FEATURES, DISEASE EVOLUTION AND OUTCOME IN A SERIES OF 100 PATIENTS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 223, doi. 10.1002/hon.38_2630
- By:
- Publication type:
- Article
PEMBROLIZUMAB MONOTHERAPY IN PATIENTS WITH PRIMARY REFRACTORY CLASSICAL HODGKIN LYMPHOMA: SUBGROUP ANALYSIS OF THE PHASE 2 KEYNOTE-087 STUDY.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 136, doi. 10.1002/hon.2437_125
- By:
- Publication type:
- Article